CAFC
21-2121
Mylan Pharmaceuticals Inc v. Merck Sharp & Dohme Corp
General
Filed07/09/21
Appeal FromPTAB
Originating CaseIPR2020-00040
Decision09/29/22
Appeal OutcomeAppellee
PACER21-2121
Judges
Judge | Cases | PO Affirm Rate | Ch Affirm Rate |
|---|---|---|---|
| Alan D. Lourie | 2000+ | 80% | 32% |
| Jimmie V. Reyna | 1000+ | 78% | 29% |
| Kara F. Stoll | 800+ | 76% | 31% |
Appellant
Attorney
Name | Ratings |
|---|---|
L2 E | |
L1 C | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys
Appellee
Attorney
Name | Ratings |
|---|---|
L3 B | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
L2 B | |
L5 A | |
-- -- -- | |
-- -- -- | |
-- -- -- | |
-- -- -- |
No Attorneys